earnings
confidence high
sentiment neutral
materiality 0.65
ReWalk Q4 revenue $2.2M (+75% YoY); full-year net loss $19.6M; cash $67.9M no debt
Lifeward Ltd.
2023-FY EPS reported
-$0.31
revenue$5,511,000
- Q4 2022 revenue $2.2M, up 75% from $1.2M in Q4 2021; full-year revenue $5.5M vs $6.0M in 2021.
- Q4 net loss $5.3M ($3.9M in Q4 2021); full-year net loss $19.6M ($12.7M in 2021).
- Cash and equivalents $67.9M as of Dec 31, 2022, with no debt.
- Submitted first exoskeleton claim for Medicare coverage via MACs in Q4; preparing for expanded patient access.
- Repurchased $3.3M of ordinary shares since Q3 2022; record quarterly MyoCycle sales.